RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

Authors: A Godal
A Soriani
AD Kaiser
AW MacFarlane
Bianca Simon
BJ Cameron
BM Olson
C Bender
C Garrido
C Krug
CH June
CH Lamers
CH Lamers
CT Morita
DC Deniger
DC Deniger
Dennis C. Harrer
DM Barrett
EJ Cheadle
ESDR
F Halary
F Koning
F Shi
F Tas
G Fiorentini
Gerold Schuler
GL Beatty
GP Linette
H Kobayashi
H Kobayashi
HJ Gober
J Dorrie
J Nakajima
Jan Dörrie
JH Berg van den
JM Tordsson
K Birkholz
K Birkholz
K Shimizu
K Waki
Kanako Shimizu
Kerstin F. Gerer
KF Gerer
KJ Curran
L Baitsch
L DeFrancesco
L Oevermann
L Ohrmalm
LA Johnson
LT Veken van der
LT Veken van der
M Lehner
ME Dudley
MR Campoli
MR Parkhurst
MR Wick
MT Spiotto
MV Maus
MV Maus
N Schaft
Niels Schaft
O Nussbaumer
PF Robbins
R Debets
RA Morgan
RE Coleman
RJ Critchley-Thorne
RJ Critchley-Thorne
S Chiplunkar
S Hofflin
S Nedellec
S Rothenfusser
S Yadavilli
SA Grupp
Shin-ichiro Fujii
Stefanie Hoyer
T Blankenstein
T Saito
T Sugie
T Zhang
U Ozerdem
U Ozerdem
Ugur Uslu
X Wang
Y Tanaka
Y Xiong
Y Zhao
Y Zhao
Y Zhao
Publication date
Publisher: 'Springer Science and Business Media LLC'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Crossref

redirect

info:doi/10.1186%2Fs12885-017-...

Last time updated on 11/12/2019